Home Cart Sign in  
Chemical Structure| 1161921-82-9 Chemical Structure| 1161921-82-9

Structure of BAY-85-8501
CAS No.: 1161921-82-9

Chemical Structure| 1161921-82-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

BAY-85-8501 is an efficient and selective human neutrophil elastase (HNE) inhibitor with an IC50 of 65 pM, used to study various HNE-mediated inflammatory diseases such as chronic obstructive pulmonary disease (COPD) and other respiratory diseases.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of BAY-85-8501

CAS No. :1161921-82-9
Formula : C22H17F3N4O3S
M.W : 474.46
SMILES Code : FC(F)(F)C1=CC=CC(N(C(N(C)[C@@]2(C3=C(S(=O)(C)=O)C=C(C#N)C=C3)[H])=O)C(C)=C2C#N)=C1
MDL No. :MFCD30532744

Safety of BAY-85-8501

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Human neutrophil elastase (HNE) 65 pM Evaluation of BAY-85-8501's inhibitory activity against HNE, showing extremely high potency. PMC4515084

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Acute lung injury (ALI) model Intratracheal instillation 0.01 mg/kg and 0.1 mg/kg Single dose, evaluated after 1 hour Evaluation of BAY-85-8501's efficacy in the ALI model, showing significant reduction in lung injury and inflammation. PMC4515084

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.11mL

0.42mL

0.21mL

10.54mL

2.11mL

1.05mL

21.08mL

4.22mL

2.11mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories